IRF7 and COVID-19: Studies have shown that the expression level of IRF7 is increased in patients with mild/moderate COVID-19 (Li N. et al., 2021), while those with reduced IRF7 expression due to hypermethylation of the IRF7 promoter gene are likely to develop severe infection after SARS-CoV-2 infection (Liu and Hill, 2020).